| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0014-2999(97)01178-3 |
| P698 | PubMed publication ID | 9369349 |
| P2093 | author name string | E E Müller | |
| V De Gennaro Colonna | |||
| F Berti | |||
| G Rossoni | |||
| M Bernareggi | |||
| P2860 | cites work | Nitric Oxide and Prostacyclin Influence Coronary Vasomotor Tone in Perfused Rabbit Heart and Modulate Endothelin-1 Activity | Q72098797 |
| Role of prostacyclin in the preservation of ischemic myocardial tissue in the perfused cat heart | Q72152084 | ||
| Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum | Q72152941 | ||
| Somatotropic dysfunction in growth hormone-releasing hormone-deprived neonatal rats: effect of growth hormone replacement therapy | Q72378320 | ||
| Growth hormone and the heart | Q72507343 | ||
| GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats | Q72678414 | ||
| Hexarelin stimulation of growth hormone release and mRNA levels in an infant and adult rat model of impaired GHRH function | Q73150234 | ||
| Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion | Q34024896 | ||
| Systemic administration of growth hormone-releasing peptide activates hypothalamic arcuate neurons. | Q34061977 | ||
| Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure | Q34201012 | ||
| Premature mortality due to cardiovascular disease in hypopituitarism | Q38516015 | ||
| Physiological role of the insulin-like growth factor binding proteins | Q40548950 | ||
| Role of selected endogenous peptides in growth hormone-releasing hexapeptide activity: analysis of growth hormone-releasing hormone, thyroid hormone-releasing hormone, and gonadotropin-releasing hormone | Q41627699 | ||
| Defibrotide, an antithrombotic substance that preserves postsynaptic alpha- and beta-adrenergic function in post acute infarcted rabbit hearts | Q41834516 | ||
| A nonpeptidyl growth hormone secretagogue | Q42558239 | ||
| Beneficial effects of iloprost in the stunned canine myocardium | Q43831277 | ||
| Long-term changes of somatotrophic function induced by deprivation of growth hormone-releasing hormone during the fetal life of the rat. | Q48225625 | ||
| On the actions of the growth hormone-releasing hexapeptide, GHRP. | Q48749637 | ||
| Worsening of ischemic damage in hearts from rats with selective growth hormone deficiency | Q48886766 | ||
| The effects of a growth hormone-releasing Peptide and growth hormone-releasing factor in conscious and anaesthetized rats. | Q52591898 | ||
| Nonsteroidal Antiinflammatory Drugs Aggravate Acute Myocardial Ischemia in the Perfused Rabbit Heart | Q62837812 | ||
| Defibrotide, an antithrombotic substance which prevents myocardial contracture in ischemic rabbit heart | Q68957385 | ||
| Growth hormone (GH) deprivation induced by passive immunization against rat GH-releasing factor delays sexual maturation in the male rat | Q69198933 | ||
| The role of growth hormone-releasing factor and somatostatin on somatic growth in rats | Q69875663 | ||
| Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay | Q69907502 | ||
| Antibodies to growth hormone-releasing factor inhibit somatic growth | Q70489122 | ||
| The effect of insulin-like growth factor-1 on adult rat cardiac contractility | Q71918825 | ||
| P433 | issue | 2-3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 201-207 | |
| P577 | publication date | 1997-09-01 | |
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: protection by hexarelin | |
| P478 | volume | 334 |
| Q47908756 | A Growth Hormone Secretagogue Prevents Ischemic-Induced Mortality Independently of the Growth Hormone Pathway in Dogs with Chronic Dilated Cardiomyopathy |
| Q61449136 | A Linear Fragment of Unacylated Ghrelin (UAG) Protects Against Myocardial Ischemia/Reperfusion Injury in Mice in a Growth Hormone Secretagogue Receptor-Independent Manner |
| Q77794109 | Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans |
| Q34231668 | Biologic activities of growth hormone secretagogues in humans |
| Q73098660 | Cardiac effects of hexarelin in hypopituitary adults |
| Q48611455 | Current topics in GH secretagogue research--introduction |
| Q36636409 | Effect of ghrelin and its analogues, BIM-28131 and BIM-28125, on the expression of myostatin in a rat heart failure model |
| Q52042600 | GH-independent cardiotropic activities of hexarelin in patients with severe left ventricular dysfunction due to dilated and ischemic cardiomyopathy. |
| Q36349408 | Ghrelin and GHS on cardiovascular applications/functions |
| Q33754189 | Ghrelin and cardiovascular diseases |
| Q35045389 | Growth hormone secretagogues modulate the electrical and contractile properties of rat skeletal muscle through a ghrelin-specific receptor |
| Q30650663 | Growth hormone-releasing hormone and growth hormone secretagogue-receptor ligands: focus on reproductive system |
| Q37089762 | Hexarelin Signaling to PPARgamma in Metabolic Diseases |
| Q43588259 | Hexarelin, but not growth hormone, protects heart from damage induced in vitro by calcium deprivation replenishment |
| Q81957491 | Hexarelin: a multi-receptor peptide |
| Q38341934 | Implications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases |
| Q83989181 | KP-102 (growth hormone-releasing peptide-2) attenuates ischemia/reperfusion injury in isolated rat hearts |
| Q34635506 | Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity |
| Q33944120 | Preclinical pharmacology of CP-424,391, an orally active pyrazolinone-piperidine [correction of pyrazolidinone-piperidine] growth hormone secretagogue |
| Q33565870 | Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Historical Appraisal of the Evidences Supporting Their Cytoprotective Effects |
| Q78107641 | Synthetic peptides and their non-peptidyl mimetics in endocrinology: from synthesis to clinical perspectives |
| Q54945060 | The CD36-PPARγ Pathway in Metabolic Disorders. |
| Q33701469 | The growth hormone secretagogue receptor |
| Q45125378 | There are no acute cardiac effects of a single iv dose of human ghrelin in severe growth hormone deficient patients |
Search more.